<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="case-report">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MI</journal-id>
<journal-title-group>
<journal-title>Medicine International</journal-title>
</journal-title-group>
<issn pub-type="ppub">2754-3242</issn>
<issn pub-type="epub">2754-1304</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">MI-5-6-00277</article-id>
<article-id pub-id-type="doi">10.3892/mi.2025.277</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Accessory breast granulomatous mastitis: A case report and mini-review of the literature</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Salih</surname><given-names>Abdulwahid M.</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Abdullah</surname><given-names>Ari M.</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
<xref rid="af2-MI-5-6-00277" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pshtiwan</surname><given-names>Lana R.A.</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Arif</surname><given-names>Sakar O.</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hammood</surname><given-names>Zuhair D.</given-names></name>
<xref rid="af3-MI-5-6-00277" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tofiq</surname><given-names>Shaban L.</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Abdullah</surname><given-names>Hiwa O.</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ahmed</surname><given-names>Masty K.</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fatih</surname><given-names>Harzal Hiwa</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Abdulkarim</surname><given-names>Meer M.</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kakamad</surname><given-names>Fahmi H.</given-names></name>
<xref rid="af1-MI-5-6-00277" ref-type="aff">1</xref>
<xref rid="af4-MI-5-6-00277" ref-type="aff">4</xref>
<xref rid="af5-MI-5-6-00277" ref-type="aff">5</xref>
<xref rid="c1-MI-5-6-00277" ref-type="corresp"/>
</contrib>
</contrib-group>
<aff id="af1-MI-5-6-00277"><label>1</label>Department of Scientific Affairs, Smart Health Tower, Sulaymaniyah 46001, Iraq</aff>
<aff id="af2-MI-5-6-00277"><label>2</label>Department of Pathology, Sulaymaniyah Teaching Hospital, Sulaymaniyah 46001, Iraq</aff>
<aff id="af3-MI-5-6-00277"><label>3</label>Department of Surgery, Tikrit Teaching Hospital, Tikrit, Saladin Governorate 34001, Iraq</aff>
<aff id="af4-MI-5-6-00277"><label>4</label>College of Medicine, University of Sulaimani, Sulaymaniyah 46001, Iraq</aff>
<aff id="af5-MI-5-6-00277"><label>5</label>Kscien Organization for Scientific Research (Middle East Office), Sulaymaniyah 46001, Iraq</aff>
<author-notes>
<corresp id="c1-MI-5-6-00277"><italic>Correspondence to:</italic> Dr Fahmi H. Kakamad, College of Medicine, University of Sulaimani, HC8V+F66, Madam Mitterrand Street, Sulaymaniyah 46001, Iraq <email>kakamad.fahmi@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="collection"><season>Nov-Dec</season><year>2025</year></pub-date>
<pub-date pub-type="epub"><day>23</day><month>10</month><year>2025</year></pub-date>
<volume>5</volume>
<issue>6</issue>
<elocation-id>78</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>08</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>10</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2025 Salih et al.</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
<abstract>
<p>Granulomatous mastitis (GM) is a rare inflammatory condition that primarily affects the breasts, and its occurrence in accessory breast tissue is even rarer. The present report describes the case of a patient with GM in the accessory breast. A 43-year-old female patient presented with a 1-month history of pain in the left axilla and breast. An analysis of her medical and surgical history did not reveal any notable findings, but she had a history of four full-term pregnancies and a cumulative lactation period of 4 years. Upon a clinical examination, a palpable, ill-defined, tender mass was noted along with an accessory breast and nipple in the axilla. The diagnosis was chronic mastitis, and she was treated with oral corticosteroids, amoxicillin, cabergoline and analgesics. Her condition initially improved; however, the symptoms recurred 1 year later. A wide local excision of the left axillary tail was performed. The patient experienced marked improvement post-surgery and remained stable, with no recurrence, at the 1-year follow-up. In addition, in the present study, seven recent cases of GM were included for a brief literature review, involving patients aged 23 to 42 years. Of these cases, 6 cases did not have any notable medical histories. A total of 6 patients had a history of pregnancy, with an average lactation duration of 22.7 months. The right breast was affected in 6 cases. Pain and swelling were the most frequent symptoms. A conservative approach, which included antibiotics, corticosteroids and wound dressing was used for 5 patients. In total, 6 patients achieved recovery. On the whole, the present study demonstrates that accessory breast tissue can develop GM. While corticosteroids may provide favorable short-term results, they do not necessarily prevent recurrence, whereas surgical management may provide more durable long-term outcomes.</p>
</abstract>
<kwd-group>
<kwd>granulomatous mastitis</kwd>
<kwd>accessory breast</kwd>
<kwd>corticosteroids</kwd>
<kwd>breast inflammation</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding:</bold> No funding was received.</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Granulomatous mastitis (GM) is a rare inflammatory condition of the breast that primarily affects women of childbearing age, often with a history of breastfeeding. GM is categorized into idiopathic or primary GM and secondary GM (<xref rid="b1-MI-5-6-00277" ref-type="bibr">1</xref>,<xref rid="b2-MI-5-6-00277" ref-type="bibr">2</xref>). It primarily involves the mammary gland, although in rare cases, it can develop in accessory breast tissue (<xref rid="b2-MI-5-6-00277" ref-type="bibr">2</xref>). While the exact cause of GM remains unclear, the leading hypothesis suggests an autoimmune origin. Various factors, including medications, diabetes, trauma and smoking, may trigger the inflammatory response. However, the strongest associations with GM are pregnancy, lactation and hyperprolactinemia. The disease accounts for &#x003C;1&#x0025; of breast biopsies (<xref rid="b3-MI-5-6-00277" ref-type="bibr">3</xref>). Despite being a benign disease, GM is frequently difficult to detect, as it often masquerades as breast carcinoma, which is the primary concern at the clinical stage (<xref rid="b4-MI-5-6-00277" ref-type="bibr">4</xref>). Its locally aggressive character causes long-term discomfort and distress for affected patients. Its non-specific imaging findings can lead to delayed diagnosis, misinterpretation and potentially unnecessary invasive procedures. Only a limited number of cases of GM in axillary breast tissue have been documented (<xref rid="b1-MI-5-6-00277" ref-type="bibr">1</xref>,<xref rid="b2-MI-5-6-00277" ref-type="bibr">2</xref>). The present report describes the case of a 43-year-old female patient with GM in the accessory breast. The report has been organized following the CaReL guidelines, and only reliable, peer-reviewed sources were included, while excluding any untrustworthy references or data (<xref rid="b5-MI-5-6-00277" ref-type="bibr">5</xref>,<xref rid="b6-MI-5-6-00277" ref-type="bibr">6</xref>).</p>
</sec>
<sec sec-type="Case|report">
<title>Case report</title>
<sec>
<title/>
<sec>
<title>Patient information</title>
<p>A 43-year-old lactating woman presented to the Breast Clinic at Smart Health Tower (Sulaymaniyah, Iraq) with a 1-month history of pain in the left axilla and breast. An analysis of her past medical and surgical history did not reveal any notable findings. She had a history of four full-term pregnancies and a cumulative lactation period of 4 years.</p>
</sec>
<sec>
<title>Clinical examination</title>
<p>The clinical examination revealed a palpable, ill-defined area of hardness with a firm consistency and tenderness upon palpation. Additionally, an axillary breast with a nipple was noted (<xref rid="f1-MI-5-6-00277" ref-type="fig">Fig. 1</xref>).</p>
</sec>
<sec>
<title>Diagnostic approach</title>
<p>A breast ultrasonography demonstrated bilateral axillary breast tissue, more prominent on the left side, containing two distinct heterogeneous collections, the largest measuring 36x9 mm. Mild edema, skin sinuses and non-specific axillary nodes were also observed. These findings are consistent with chronic mastitis involving axillary breast tissue (<xref rid="f2-MI-5-6-00277" ref-type="fig">Fig. 2</xref>) (<xref rid="b1-MI-5-6-00277" ref-type="bibr">1</xref>).</p>
</sec>
<sec>
<title>Therapeutic intervention</title>
<p>The patient was initially diagnosed with periductal mastitis and managed medically with a tapering course of oral corticosteroids (prednisolone 10 mg once daily for 20 days, followed by 5 mg once daily for an additional 20 days; this was used to suppress the immune-mediated inflammatory process underlying GM and to reduce swelling, pain and disease activity), in combination with amoxicillin (1 g three times daily for 7 days, to cover potential secondary bacterial infection, which may complicate the course of GM, particularly when abscesses, fistulae, or skin involvement are present), cabergoline (0.5 mg once daily for 2 days, to suppress prolactin secretion) and analgesics (co-codamol 500 mg, two tablets as needed for pain control). She demonstrated a good clinical response to this regimen; however, the condition recurred 1 year later. Following multidisciplinary team discussion, a wide local excision of the left axillary tail was performed. A histopathological analysis of the excised specimen was performed on 5-&#x00B5;m-thick sections fixed in 10&#x0025; neutral-buffered formalin for 24 h, embedded in paraffin, and stained with hematoxylin and eosin (Bio Optica Co.) for 1-2 min at room temperature. Examination under a light microscope (Leica Microsystems GmbH) revealed xanthogranulomatous inflammation involving the axillary accessory breast tissue, along with benign lymph nodes showing acute lymphadenitis (<xref rid="f3-MI-5-6-00277" ref-type="fig">Fig. 3</xref>).</p>
</sec>
<sec>
<title>Follow-up and outcome</title>
<p>At the 2-month follow-up time point, the symptoms of the patient had markedly improved, with no signs of recurrence. At the most recent annual follow-up following surgical excision, she remained in good health and recurrence-free.</p>
</sec>
</sec>
</sec>
<sec sec-type="Discussion">
<title>Discussion</title>
<p>Accessory breast tissue arises along the embryonic mammary ridge, extending from the axilla to the pubic region, and is susceptible to the same pathological conditions as normally located breast tissue (<xref rid="b1-MI-5-6-00277" ref-type="bibr">1</xref>). The frequently reported conditions in accessory breast tissue include cancer, mastitis, fibroadenomas, phyllodes tumors and fibrocystic changes (<xref rid="b7-MI-5-6-00277" ref-type="bibr">7</xref>). The leading hypothesis regarding the pathogenesis of GM suggests that an autoimmune response is initiated within the lobules of the breast parenchyma following ductal injury. This triggers a localized inflammatory reaction in the connective tissue, promoting the recruitment of macrophages and lymphocytes, ultimately resulting in a noncaseating granulomatous response (<xref rid="b3-MI-5-6-00277" ref-type="bibr">3</xref>).</p>
<p>The influence of ethnicity on GM remains a subject of debate. Vall <italic>et al</italic> (<xref rid="b3-MI-5-6-00277" ref-type="bibr">3</xref>) reported no specific ethnic predisposition. By contrast, the studies by Yuan <italic>et al</italic> (<xref rid="b8-MI-5-6-00277" ref-type="bibr">8</xref>) and Deng <italic>et al</italic> (<xref rid="b9-MI-5-6-00277" ref-type="bibr">9</xref>) indicated a higher prevalence of GM in Middle Eastern populations compared to Western countries. Consistent with the present case, GM predominantly affects women of reproductive age, particularly those with a history of breastfeeding. Among the 7 cases reviewed herein, 4 patients had a prior history of breastfeeding, with an average duration of 22.7 months (<xref rid="tI-MI-5-6-00277" ref-type="table">Table I</xref>) (<xref rid="b1-MI-5-6-00277 b2-MI-5-6-00277 b3-MI-5-6-00277 b4-MI-5-6-00277" ref-type="bibr">1-4</xref>,<xref rid="b7-MI-5-6-00277" ref-type="bibr">7</xref>,<xref rid="b10-MI-5-6-00277" ref-type="bibr">10</xref>,<xref rid="b11-MI-5-6-00277" ref-type="bibr">11</xref>). However, Nakamura <italic>et al</italic> (<xref rid="b7-MI-5-6-00277" ref-type="bibr">7</xref>) and Rajendran <italic>et al</italic> (<xref rid="b10-MI-5-6-00277" ref-type="bibr">10</xref>) documented cases of GM in women without a history of breastfeeding.</p>
<p>Bilateral involvement in GM is rare, as the condition typically presents unilaterally (<xref rid="b1-MI-5-6-00277" ref-type="bibr">1</xref>). In the patient in the present study, a breast ultrasonography identified two distinct heterogeneous collections within the left axillary breast, accompanied by mild edema and skin sinuses. These imaging findings were consistent with the characteristic manifestations of GM, which commonly include mass formation, skin changes and the development of a sinus tract. Systemic symptoms, such as fever, remain uncommon in GM cases (<xref rid="b1-MI-5-6-00277" ref-type="bibr">1</xref>). Among the cases reviewed herein, all were unilateral, with fever reported in only 1 patient. Pain was the reported symptom in 6 cases, whereas erythema was observed in only 2 cases.</p>
<p>The diagnosis of GM requires a well-coordinated multidisciplinary approach involving clinicians, radiologists and pathologists, as demonstrated in the present case report. This is particularly critical given that cases with clinical deviance or coexistence with breast cancer have been reported, increasing the risk of misdiagnosis. Multidisciplinary collaboration not only helps to avoid such errors, but also facilitates earlier preoperative diagnosis and ensures the appropriate use of corticosteroid therapy in selected patients (<xref rid="b8-MI-5-6-00277" ref-type="bibr">8</xref>,<xref rid="b12-MI-5-6-00277" ref-type="bibr">12</xref>). Due to the absence of specific clinical or radiological characteristics, imaging findings may be non-specific. Mammography often reveals asymmetric density, while an ultrasound may detect irregular, heterogeneous masses suggestive of abscesses. However, these features are not unique to GM and can mimic other breast pathologies (<xref rid="b1-MI-5-6-00277" ref-type="bibr">1</xref>).</p>
<p>Although no standardized treatment exists for GM to date, at least to the best of our knowledge, steroids are frequently used to reduce lesion size. However, their use is associated with adverse effects, such as weight gain, hyperglycemia, Cushing syndrome and opportunistic infections (<xref rid="b7-MI-5-6-00277" ref-type="bibr">7</xref>). Additionally, patient non-adherence can compromise treatment efficacy. Vall <italic>et al</italic> (<xref rid="b3-MI-5-6-00277" ref-type="bibr">3</xref>) reported a case in which poor adherence led to multiple recurrences, ultimately necessitating rescue therapy. While the studies by Alvand <italic>et al</italic> (<xref rid="b2-MI-5-6-00277" ref-type="bibr">2</xref>) Rajendran <italic>et al</italic> (<xref rid="b10-MI-5-6-00277" ref-type="bibr">10</xref>) and Oze <italic>et al</italic> (<xref rid="b4-MI-5-6-00277" ref-type="bibr">4</xref>) reported favorable outcomes with conservative management, the lack of long-term follow-up in these cases raises concerns about the sustained efficacy and reliability of conservative treatment strategies.</p>
<p>A previous meta-analysis of 138 cases undergoing surgery and 358 cases with steroid therapy revealed improved outcomes with surgery (complete response: 90.6 vs. 71.8&#x0025;; recurrence: 6.8&#x0025; vs. 20.9&#x0025;) (<xref rid="b13-MI-5-6-00277" ref-type="bibr">13</xref>). Combining surgery with steroids further improved results, with a 94.5&#x0025; complete response rate and a 4.0&#x0025; recurrence rate (<xref rid="b13-MI-5-6-00277" ref-type="bibr">13</xref>). A conservative approach was initially employed for the patient in the present study; however, recurrence occurred after 1 year. By contrast, wide local excision of the axillary tail achieved a favorable outcome, with no recurrence observed at the one-year follow-up.</p>
<p>The case described herein enriches the existing body of knowledge by elucidating the presentation, complex diagnosis, treatment options and favorable outcomes of GM in accessory breast tissue, guiding clinicians in recognizing and managing this rare condition effectively. However, it is worth mentioning that a longer period of monitoring would strengthen this report and the conclusions drawn significantly.</p>
<p>In conclusion, GM can occur in accessory breast tissue. While corticosteroids may provide favorable short-term results, they do not necessarily prevent recurrence, whereas surgical management may offer more durable long-term outcomes.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The data generated in the present study may be requested from the corresponding author.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>ZDH and AMS were major contributors to the conception of the study, as well as to the literature search for related studies. HOA, MKA and HHF were involved in the literature review, in the design of the study, and in the writing of the manuscript. SOA, SLT, MMA and FHK were involved in the literature review, in the design of the study, in the critical revision of the manuscript, analyzing patient data, and the processing of the table. LRAP was the radiologist who assessed the case. AMA was the pathologist who performed the diagnosis of the case. FHK and MMA confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Written informed consent was obtained from the patient for their participation in the present study.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Written informed consent was obtained from the patient for the publication of the present case report and any accompanying images.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-MI-5-6-00277"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salih</surname><given-names>AM</given-names></name><name><surname>Pshtiwan</surname><given-names>LR</given-names></name><name><surname>Latif</surname><given-names>S</given-names></name><name><surname>Ali</surname><given-names>HO</given-names></name><name><surname>Abdullah</surname><given-names>AM</given-names></name><name><surname>Baba</surname><given-names>HO</given-names></name><name><surname>Hama</surname><given-names>JI</given-names></name><name><surname>Hassan</surname><given-names>SH</given-names></name><name><surname>Hassan</surname><given-names>MN</given-names></name><name><surname>Mohammed</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Granulomatous mastitis in accessory breast tissue: A rare presentation and surgical management</article-title><source>Biomed Rep</source><volume>20</volume><issue>62</issue><year>2024</year><pub-id pub-id-type="pmid">38476604</pub-id><pub-id pub-id-type="doi">10.3892/br.2024.1750</pub-id></element-citation></ref>
<ref id="b2-MI-5-6-00277"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvand</surname><given-names>S</given-names></name><name><surname>Hessami</surname><given-names>A</given-names></name><name><surname>Kiani</surname><given-names>L</given-names></name><name><surname>Makhmalbaf</surname><given-names>AO</given-names></name><name><surname>Elahi</surname><given-names>A</given-names></name></person-group><article-title>Uncommon location of idiopathic granulomatous mastitis: A case report: Uncommon Location of IGM</article-title><source>Arch Breast Cancer</source><volume>9</volume><fpage>320</fpage><lpage>324</lpage><year>2022</year></element-citation></ref>
<ref id="b3-MI-5-6-00277"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vall</surname><given-names>E</given-names></name><name><surname>Araya</surname><given-names>V</given-names></name><name><surname>Tortajada</surname><given-names>L</given-names></name><name><surname>Escobedo</surname><given-names>V</given-names></name><name><surname>Nogueiras</surname><given-names>R</given-names></name><name><surname>Del Riego</surname><given-names>J</given-names></name></person-group><article-title>Idiopathic granulomatous mastitis after mRNA vaccination against COVID-19: A possible association?</article-title><source>BJR Case Rep</source><volume>11</volume><issue>uaae048</issue><year>2025</year><pub-id pub-id-type="pmid">39995498</pub-id><pub-id pub-id-type="doi">10.1093/bjrcr/uaae048</pub-id></element-citation></ref>
<ref id="b4-MI-5-6-00277"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oze</surname><given-names>KR</given-names></name><name><surname>Yehouenou Tessi</surname><given-names>RT</given-names></name><name><surname>Mendes</surname><given-names>P</given-names></name><name><surname>Allali</surname><given-names>N</given-names></name><name><surname>Chat</surname><given-names>L</given-names></name><name><surname>El Haddad</surname><given-names>S</given-names></name></person-group><article-title>Granulomatous mastitis: A case report</article-title><source>SAGE Open Med Case Rep</source><volume>10</volume><issue>2050313X221146671</issue><year>2022</year><pub-id pub-id-type="pmid">36582424</pub-id><pub-id pub-id-type="doi">10.1177/2050313X221146671</pub-id></element-citation></ref>
<ref id="b5-MI-5-6-00277"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdullah</surname><given-names>HO</given-names></name><name><surname>Abdalla</surname><given-names>BA</given-names></name><name><surname>Kakamad</surname><given-names>FH</given-names></name><name><surname>Ahmed</surname><given-names>JO</given-names></name><name><surname>Baba</surname><given-names>HO</given-names></name><name><surname>Hassan</surname><given-names>MN</given-names></name><name><surname>Bapir</surname><given-names>R</given-names></name><name><surname>Rahim</surname><given-names>HM</given-names></name><name><surname>Omar</surname><given-names>DA</given-names></name><name><surname>Kakamad</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Predatory publishing lists: A review on the ongoing battle against fraudulent actions</article-title><source>Barw Med J</source><volume>2</volume><fpage>26</fpage><lpage>30</lpage><year>2024</year></element-citation></ref>
<ref id="b6-MI-5-6-00277"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>S</given-names></name><name><surname>Nassar</surname><given-names>M</given-names></name><name><surname>Azzam</surname><given-names>AY</given-names></name><name><surname>Garci&#x0301;a-Muro-San Jose&#x0301;</surname><given-names>F</given-names></name><name><surname>Jamee</surname><given-names>M</given-names></name><name><surname>Sliman</surname><given-names>RKA</given-names></name><name><surname>Evola</surname><given-names>G</given-names></name><name><surname>Mustafa</surname><given-names>AM</given-names></name><name><surname>Abdullah</surname><given-names>HO</given-names></name><name><surname>Abdalla</surname><given-names>BA</given-names></name><etal/></person-group><article-title>CaReL Guidelines: A consensus-based guideline on case reports and literature review (CaReL)</article-title><source>Barw Med J</source><volume>2</volume><fpage>13</fpage><lpage>19</lpage><year>2024</year></element-citation></ref>
<ref id="b7-MI-5-6-00277"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>J</given-names></name><name><surname>Tanaka</surname><given-names>F</given-names></name><name><surname>Ohtaka</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Iyama</surname><given-names>A</given-names></name></person-group><article-title>A rare case of granulomatous mastitis in the accessory axillary breast of a pregnant woman successfully treated by surgery</article-title><source>Eur J Breast Health</source><volume>18</volume><issue>195</issue><year>2022</year><pub-id pub-id-type="pmid">35445183</pub-id><pub-id pub-id-type="doi">10.4274/ejbh.galenos.2021.2021-10-5</pub-id></element-citation></ref>
<ref id="b8-MI-5-6-00277"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>QQ</given-names></name><name><surname>Xiao</surname><given-names>SY</given-names></name><name><surname>Farouk</surname><given-names>O</given-names></name><name><surname>Du</surname><given-names>YT</given-names></name><name><surname>Sheybani</surname><given-names>F</given-names></name><name><surname>Tan</surname><given-names>QT</given-names></name><name><surname>Akbulut</surname><given-names>S</given-names></name><name><surname>Cetin</surname><given-names>K</given-names></name><name><surname>Alikhassi</surname><given-names>A</given-names></name><name><surname>Yaghan</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Management of granulomatous lobular mastitis: An international multidisciplinary consensus (2021 edition)</article-title><source>Mil Med Res</source><volume>9</volume><issue>20</issue><year>2022</year><pub-id pub-id-type="pmid">35473758</pub-id><pub-id pub-id-type="doi">10.1186/s40779-022-00380-5</pub-id></element-citation></ref>
<ref id="b9-MI-5-6-00277"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Ning</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>XR</given-names></name><name><surname>Tu</surname><given-names>GF</given-names></name><name><surname>He</surname><given-names>PY</given-names></name></person-group><article-title>A case management model for patients with granulomatous mastitis: A prospective study</article-title><source>BMC Women&#x0027;s Health</source><volume>22</volume><issue>143</issue><year>2022</year><pub-id pub-id-type="pmid">35501850</pub-id><pub-id pub-id-type="doi">10.1186/s12905-022-01726-w</pub-id></element-citation></ref>
<ref id="b10-MI-5-6-00277"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>D</given-names></name><name><surname>See</surname><given-names>CB</given-names></name><name><surname>Wan</surname><given-names>WM</given-names></name><name><surname>Teik</surname><given-names>CY</given-names></name></person-group><article-title>Chronic granulomatous mastitis with axillary lymphadenopathy in a nulliparous woman</article-title><source>Med J Malaysia</source><volume>74</volume><fpage>564</fpage><lpage>565</lpage><year>2019</year><pub-id pub-id-type="pmid">31929493</pub-id></element-citation></ref>
<ref id="b11-MI-5-6-00277"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shabani</surname><given-names>S</given-names></name><name><surname>Sadeghi</surname><given-names>B</given-names></name><name><surname>Zarinfar</surname><given-names>N</given-names></name><name><surname>Sarmadian</surname><given-names>R</given-names></name></person-group><article-title>Idiopathic granulomatous mastitis: A case report and literature review</article-title><source>Clin Case Rep</source><volume>11</volume><issue>e7819</issue><year>2023</year><pub-id pub-id-type="pmid">37636874</pub-id><pub-id pub-id-type="doi">10.1002/ccr3.7819</pub-id></element-citation></ref>
<ref id="b12-MI-5-6-00277"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salih</surname><given-names>AM</given-names></name><name><surname>Latif</surname><given-names>S</given-names></name><name><surname>Ali</surname><given-names>RM</given-names></name><name><surname>Pshtiwan</surname><given-names>LR</given-names></name><name><surname>Ali</surname><given-names>HO</given-names></name><name><surname>Abdullah</surname><given-names>AM</given-names></name><name><surname>Salih</surname><given-names>KM</given-names></name><name><surname>Hassan</surname><given-names>SH</given-names></name><name><surname>Nasralla</surname><given-names>HA</given-names></name><name><surname>Hussein</surname><given-names>BO</given-names></name><name><surname>Kakamad</surname><given-names>FH</given-names></name></person-group><article-title>Granulomatous mastitis co-existing with breast cancer: A case report and mini-review of the literature</article-title><source>World Acad Sci J</source><volume>7</volume><issue>101</issue><year>2025</year></element-citation></ref>
<ref id="b13-MI-5-6-00277"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Su</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>Treatments for idiopathic granulomatous mastitis: Systematic review and meta-analysis</article-title><source>Breastfeed Med</source><volume>12</volume><fpage>415</fpage><lpage>421</lpage><year>2017</year><pub-id pub-id-type="pmid">28731822</pub-id><pub-id pub-id-type="doi">10.1089/bfm.2017.0030</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-MI-5-6-00277" position="float">
<label>Figure 1</label>
<caption><p>Image of the axillary region illustrating an area of hyperpigmentation with an indurated appearance. A small, isolated sinus tract is visible, indicating underlying chronic inflammation. The affected region corresponds to the axillary tail of Spence, where ectopic breast tissue is present. The surrounding skin appears slightly thickened, with mild erythema suggesting an ongoing inflammatory process.</p></caption>
<graphic xlink:href="mi-05-06-00277-g00.tif"/>
</fig>
<fig id="f2-MI-5-6-00277" position="float">
<label>Figure 2</label>
<caption><p>Grayscale ultrasound of the right axilla demonstrating accessory breast tissue with heterogeneous parenchymal echotexture and mild edema, consistent with mastitis. The numbers &#x2018;1&#x2019; and &#x2018;2&#x2019; designate the two orthogonal caliper sets used to measure the long- and short-axis of the lesion, respectively; the yellow crosses indicate the caliper endpoints. The recorded dimensions are 36x9 mm (long x short)</p></caption>
<graphic xlink:href="mi-05-06-00277-g01.tif"/>
</fig>
<fig id="f3-MI-5-6-00277" position="float">
<label>Figure 3</label>
<caption><p>(A) Section of skin covered by benign epidermis (black arrows) with underlying tissue containing a lactiferous duct (red arrow). Hematoxylin and eosin staining; magnification, x4. (B) Higher magnification demonstrating multiple benign lactiferous ducts lined by ductal epithelial cells (black arrows). Hematoxylin and eosin staining; magnification, x10. (C) Section illustrating a benign lactiferous duct (black arrow) surrounded by tissue heavily infiltrated with mixed inflammatory cells and foamy macrophages (black stars). Hematoxylin and eosin staining; magnification, x4. (D) Higher magnification image illustrating multinucleated giant cells (black arrows) with ill-formed epithelioid histiocyte aggregates (red arrows) and dense mixed inflammatory cell infiltration (black star). Hematoxylin and eosin staining; magnification, x10.</p></caption>
<graphic xlink:href="mi-05-06-00277-g02.tif"/>
</fig>
<table-wrap id="tI-MI-5-6-00277" position="float">
<label>Table I</label>
<caption><p>Relevant variables of the reviewed cases.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">First author, year of publication</th>
<th align="center" valign="middle">Age, years</th>
<th align="center" valign="middle">Medical history</th>
<th align="center" valign="middle">Use of contraceptives</th>
<th align="center" valign="middle">No. of pregnancies</th>
<th align="center" valign="middle">History of lactation</th>
<th align="center" valign="middle">Duration of lactation (months)</th>
<th align="center" valign="middle">Affected side</th>
<th align="center" valign="middle">Symptoms</th>
<th align="center" valign="middle">Axillary involvement</th>
<th align="center" valign="middle">Treatment approach</th>
<th align="center" valign="middle">Outcome</th>
<th align="center" valign="middle">Follow-up (years)</th>
<th align="center" valign="middle">(Refs.)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Vall, 2025</td>
<td align="center" valign="middle">24</td>
<td align="left" valign="middle">Unexceptional</td>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">18</td>
<td align="left" valign="middle">Left</td>
<td align="left" valign="middle">Erythema, pain and edema</td>
<td align="center" valign="middle">Yes</td>
<td align="left" valign="middle">Oral corticosteroid followed by rescue therapy due to poor adherence</td>
<td align="left" valign="middle">A few episodes of recurrence with subsequent recovery</td>
<td align="center" valign="middle">N/A</td>
<td align="center" valign="middle">(<xref rid="b3-MI-5-6-00277" ref-type="bibr">3</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle">Salih, 2024</td>
<td align="center" valign="middle">39</td>
<td align="left" valign="middle">Left breast granulomatous mastitis</td>
<td align="left" valign="middle">N/A</td>
<td align="center" valign="middle">3</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">37</td>
<td align="left" valign="middle">Right</td>
<td align="left" valign="middle">Right, axillary discomfort, swelling, redness, fever and chills</td>
<td align="center" valign="middle">Yes</td>
<td align="left" valign="middle">Oral amoxicillin and clavulanic acid, followed by excisional biopsy</td>
<td align="left" valign="middle">Recovery</td>
<td align="center" valign="middle">0.5</td>
<td align="center" valign="middle">(<xref rid="b1-MI-5-6-00277" ref-type="bibr">1</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle">Shabani, 2023</td>
<td align="center" valign="middle">38</td>
<td align="left" valign="middle">Unexceptional</td>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">12</td>
<td align="left" valign="middle">Right</td>
<td align="left" valign="middle">Painful mass, thickened skin and warmth</td>
<td align="center" valign="middle">No</td>
<td align="left" valign="middle">Oral corticosteroid</td>
<td align="left" valign="middle">Recovery</td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">(<xref rid="b11-MI-5-6-00277" ref-type="bibr">11</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle">Nakamura, 2022</td>
<td align="center" valign="middle">24</td>
<td align="left" valign="middle">Unexceptional</td>
<td align="left" valign="middle">N/A</td>
<td align="center" valign="middle">Pregnant at the time of presentation</td>
<td align="center" valign="middle">No</td>
<td align="center" valign="middle">N/A</td>
<td align="left" valign="middle">Right</td>
<td align="left" valign="middle">Pain and swelling</td>
<td align="center" valign="middle">Yes</td>
<td align="left" valign="middle">Intravenous piperacillin, drainage and surgical removal</td>
<td align="left" valign="middle">Recovery</td>
<td align="center" valign="middle">N/A</td>
<td align="center" valign="middle">(<xref rid="b7-MI-5-6-00277" ref-type="bibr">7</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle">Oze, 2022</td>
<td align="center" valign="middle">42</td>
<td align="left" valign="middle">Unexceptional</td>
<td align="left" valign="middle">Contraceptive device after her last child</td>
<td align="center" valign="middle">5</td>
<td align="center" valign="middle">N/A</td>
<td align="center" valign="middle">N/A</td>
<td align="left" valign="middle">Right</td>
<td align="left" valign="middle">Swelling, nipple retraction</td>
<td align="center" valign="middle">Yes</td>
<td align="left" valign="middle">Antibiotic therapy and wound dressings</td>
<td align="left" valign="middle">Recovery</td>
<td align="center" valign="middle">0.5</td>
<td align="center" valign="middle">(<xref rid="b4-MI-5-6-00277" ref-type="bibr">4</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle">Alvand, 2022</td>
<td align="center" valign="middle">36</td>
<td align="left" valign="middle">Unexceptional</td>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">24</td>
<td align="left" valign="middle">Right</td>
<td align="left" valign="middle">Pain, swelling and skin thickening</td>
<td align="center" valign="middle">Yes</td>
<td align="left" valign="middle">Prednisone, naproxen</td>
<td align="left" valign="middle">Recovery</td>
<td align="center" valign="middle">0.75</td>
<td align="center" valign="middle">(<xref rid="b2-MI-5-6-00277" ref-type="bibr">2</xref>)</td>
</tr>
<tr>
<td align="left" valign="middle">Rajendran, 2019</td>
<td align="center" valign="middle">23</td>
<td align="left" valign="middle">Unexceptional</td>
<td align="left" valign="middle">N/A</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">No</td>
<td align="center" valign="middle">N/A</td>
<td align="left" valign="middle">Right</td>
<td align="left" valign="middle">Pain and swelling</td>
<td align="center" valign="middle">Yes</td>
<td align="left" valign="middle">Oral azithromycin and oral prednisone</td>
<td align="left" valign="middle">Recovery</td>
<td align="center" valign="middle">N/A</td>
<td align="center" valign="middle">(<xref rid="b10-MI-5-6-00277" ref-type="bibr">10</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>N/A, not applicable.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
